In my role in AstraZeneca I am responsible for applying drug delivery approaches which have the potential to enable the progression of innovative medicines. I have been instrumental in introducing nanomedicines into the AstraZeneca portfolio, and initiated several key collaborations, building internal capability in nanomedicines and drug targeting.
I have a PhD in oral drug delivery to the colon, and a degree in Pharmacy from the University of Manchester.
Having published over 55 peer reviewed papers and six book chapters, I also regularly deliver invited talks, keynotes and plenaries worldwide in nanomedicine and advanced drug delivery.
I am an Honorary Professor at the University of Nottingham and serve on numerous academic and industrial scientific committees and advisory boards in the field of drug delivery.
Cutting edge drug delivery technologies that enable more drug to specifically engage with the target are critical to translating benefits of new exciting molecules to patients
CURRENT ROLE
2018
2017
2016